Thomas E. Dever
Affiliations: | Protein Biosynthesis | National Institutes of Health, Bethesda, MD |
Area:
Gene Regulation and DevelopmentWebsite:
http://deverlab.nichd.nih.gov/dever_bio.htmGoogle:
"Thomas Edward Dever"Mean distance: 10.69
Parents
Sign in to add mentorWilliam C. Merrick | grad student | 1990 | Case Western | |
(Characterization of eukaryotic protein synthesis factors) | ||||
Alan G. Hinnebusch | post-doc | 1990-1994 | NICHD |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Grosely R, Alvarado C, Ivanov IP, et al. (2024) eIF1 and eIF5 dynamically control translation start site fidelity. Biorxiv : the Preprint Server For Biology |
Dever TE, Ivanov IP, Hinnebusch AG. (2023) Translational regulation by uORFs and start codon selection stringency. Genes & Development. 37: 474-489 |
Shin BS, Ivanov IP, Kim JR, et al. (2023) eEF2 diphthamide modification restrains spurious frameshifting to maintain translational fidelity. Nucleic Acids Research |
Wang J, Shin BS, Alvarado C, et al. (2022) Rapid 40S scanning and its regulation by mRNA structure during eukaryotic translation initiation. Cell. 185: 4474-4487.e17 |
Lapointe CP, Grosely R, Sokabe M, et al. (2022) eIF5B and eIF1A reorient initiator tRNA to allow ribosomal subunit joining. Nature |
Ivanov IP, Saba JA, Fan CM, et al. (2022) Evolutionarily conserved inhibitory uORFs sensitize mRNA translation to start codon selection stringency. Proceedings of the National Academy of Sciences of the United States of America. 119 |
Wang J, Wang J, Shin BS, et al. (2020) Structural basis for the transition from translation initiation to elongation by an 80S-eIF5B complex. Nature Communications. 11: 5003 |
Dever TE, Ivanov IP, Sachs MS. (2020) Conserved Upstream Open Reading Frame Nascent Peptides that Control Translation. Annual Review of Genetics |
Kotzaeridou U, Young-Baird SK, Suckow V, et al. (2020) Novel pathogenic EIF2S3 missense variants causing clinically variable MEHMO syndrome with impaired eIF2γ translational function, and literature review. Clinical Genetics |
Young-Baird SK, Lourenço MB, Elder MK, et al. (2019) Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB. Molecular Cell |